JuSun
- Twist Bioscience Corporation (NASDAQ:TWST) added ~16% on Monday to mark the biggest intraday gain since November after its senior vice president Dennis Cho disclosed the purchase of 10K shares of the synthetic biology company.
- According to a regulatory filing on Friday, Cho, who serves as TWST’s general counsel and chief ethics and compliance officer, bought the shares last week at $13.20 apiece, increasing his stake by more than 50%.
- The transaction worth over $132K marks Twist’s (TWST) first insider purchase in a year and comes ahead of an industry conference in Antwerp, Belgium, where the company’s CEO Emily Leproust is scheduled to present on Wednesday.
- The presentation titled “Scaling SemiSynBio to fuel the growth towards a $1T semiconductor industry” will focus on how to drive industry growth using CMOS-based chips for high-density DNA synthesis for data storage applications.